CARMEN NG: Open Payments
NPI 1073288015 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 9 payments from 7 companies in 2025. Trend: 2023 $178 · 2024 $1,156 · 2025 $1,130
Food & beverage: $1,053Education: $77
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 3 | $374 |
| Mirum Pharmaceuticals, Inc. | 1 | $150 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Boston Scientific Corporation | 1 | $143 |
| Aimmune Therapeutics, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Janssen Biotech, Inc. | 1 | $77 |
Products named: Bylvay, Livmarli, REZDIFFRA, AMS 700, IQIRVO, ZENPEP, AUSTEDO XR, TREMFYA.
Industry payments across TX — which companies pay providers there.
